儿科病例克朗氏病,免疫球蛋白A脏病和亚托皮性皮肤炎
Yoshihiko Sugino1, Hideki Ban2, Yuichiro Yoshino3
1Department of Pediatric Gastroenterology and Hepatology, Japanese Red Cross Kumamoto Hospital, Kumamoto, Japan.
这份病例报告详细介绍了一名患有克罗恩病 (CD) 的儿科患者,该患者患有免疫球蛋白A脏病 (IgAN) 和严重的亚托皮性皮肤炎 (AD). 与上达西提尼布和因弗利克西玛布同时治疗,在所有三种疾病中实现了缓解.
科学领域:
- 儿科胃肠病学 儿科胃肠病学
- 腎臟病學 (nephrology) 是一種醫學專業.
- 皮肤病学 皮肤病学
背景情况:
- 克罗恩氏病 (CD) 可能伴有脏并发症,如免疫球蛋白A脏病 (IgAN).
- 在儿科病例中,与CD和IgAN并发的严重亚托皮炎 (AD) 异常罕见.
- 本报告侧重于一个独特的儿科病例,其中有这些同时发生的疾病.
研究的目的:
- 报告一例罕见的儿科患者同时患有克罗恩病,免疫球蛋白A脏病和严重的亚托皮性皮肤炎.
- 描述这个复杂的儿科病例的治疗过程和结果.
- 要突出成功管理这三个不同的条件.
主要方法:
- 一个10岁男孩被诊断患有克罗恩氏病的案例报告.
- 记录了免疫球蛋白A脏病和严重的亚托皮性皮肤炎随着时间的推移而发展的情况.
- 与此同时使用的药物包括upadacitinib和infliximab.
主要成果:
- 这位患者的病史复杂,涉及CD,Igan和严重的AD.
- 这三种情况的顺利缓解是通过联合治疗Upadacitinib和Infliximab而实现的.
- 这个案例证明了对这些同时存在的儿科疾病的同时治疗的可行性.
结论:
- 同时的CD,Igan和严重的AD是一种罕见但可管理的儿科疾病.
- 在治疗这些复杂的儿科病例时,可以有效地使用upadacitinib和infliximab.
- 这个案例突出了一个成功的治疗策略,用于一个具有挑战性的临床表现.
更多相关视频
09:32Resolving Water, Proteins, and Lipids from In Vivo Confocal Raman Spectra of Stratum Corneum through a Chemometric Approach
Published on: September 26, 2019
10:27Recognition of Epidermal Transglutaminase by IgA and Tissue Transglutaminase 2 Antibodies in a Rare Case of Rhesus Dermatitis
Published on: December 15, 2011
相关概念视频
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
